Endoscopic Stenting in Crohn Related Strictures
Not Applicable
Completed
- Conditions
- Intestinal Strictures Related to Crohn´s Disease
- Registration Number
- NCT04718493
- Lead Sponsor
- Sahlgrenska University Hospital, Sweden
- Brief Summary
Prospective, randomized-controlled trial comparing self-expandable metal stent versus ballon dialtation only for the endoscopic treatment of benign strictures related to Crohn´s disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 13
Inclusion Criteria
- Benign high-grade Crohn stricture
Exclusion Criteria
- Unwillingness to participate
- Planned surgery
- High risk for bleeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Technical success rate Peroperative Adverse event rate Within 7 days
- Secondary Outcome Measures
Name Time Method Clinical success rate 24 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways drive fibrostenotic disease in Crohn's-related strictures and how do SEMS address them?
How does self-expandable metal stent efficacy compare to balloon dilation in Crohn's fibrostenotic stricture management?
Which biomarkers correlate with long-term patency of SEMS versus balloon dilation in Crohn's intestinal strictures?
What are the complication rates of SEMS placement versus balloon dilation in Crohn's disease stricture treatment?
Are there combination therapies with SEMS improving outcomes in Crohn's strictures compared to dilation alone?